Pfizer (NYSE: PFE)
Pfizer Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Pfizer Company Info
Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
News & Analysis
Pfizer Just Made a Landmark Drug Pricing Agreement with President Donald Trump. Is the Stock a Buy?
The pharma giant just eliminated two big risks.
Investing in Biotech Stocks in 2025
3 Things You Need to Know if You Buy Pfizer Today
Pfizer has an attractive 7.2% dividend yield, but there are some pros and cons you need to understand before you buy it.
Why Pfizer Stock Trounced the Market Today
A bullish analyst note added to the generally good sentiment on the company.
Pfizer Just Announced a Massive Deal with TrumpRx. Here's What Investors Need to Know
Pfizer's CEO says the deal with the Trump administration is "a win" for the company. He's probably right.
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
These stocks could see growth take off over the next few years.
3 Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 9.5% -- Which Are No-Brainer Buys in October
Three supercharged income stocks have the catalysts necessary to pad the pocketbooks of patient investors.
Stock Market Today: Pfizer Rallies on Trump Drug Pricing Deal and U.S. Investment Pledge
Pfizer surged after striking a landmark agreement with the Trump administration to lower drug prices and expand U.S. production.
Valuation
Podcast Episodes
A Coronavirus Vaccine Is Good News. What's Going on With Cruise Lines?
A look at stock market news.
Why Is a Coronavirus Vaccine Bad News for Some Stocks?
Investors knew that a vaccine was coming, so why did the market react the way it did?
Why Coronavirus Vaccine News Is Great for Bank Stocks and REITs
Some of our favorite banks and real estate stocks are having their best rallies in years.
2 Reasons Pfizer Is on Our Minds Today
First, it raised some spinoff speculation. Second, it's in an intriguing tussle with J&J that could affect the biosimilars market for everyone.
Earnings Transcripts
Pfizer (PFE) Q4 2024 Earnings Call Transcript
PFE earnings call for the period ending December 31, 2024.
Pfizer (PFE) Q3 2024 Earnings Call Transcript
PFE earnings call for the period ending September 30, 2024.
Pfizer (PFE) Q2 2024 Earnings Call Transcript
PFE earnings call for the period ending June 30, 2024.
Pfizer (PFE) Q1 2024 Earnings Call Transcript
PFE earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.